at www.tipranks.com (Mon, 12-Jan 10:40 PM)
TD Cowen Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
at www.tipranks.com (Mon, 12-Jan 9:37 PM)
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story
at www.tipranks.com (Thu, 8-Jan 11:34 AM)
Andrew Hill Investment Advisors adds GS, TMO, PG, DE exits COST among Q4 moves
at seekingalpha.com (Thu, 8-Jan 7:41 AM)
